142 related articles for article (PubMed ID: 9231916)
1. Fas receptor is expressed in human lung squamous cell carcinomas, whereas bcl-2 and apoptosis are not pronounced: a preliminary report.
Hellquist HB; Olejnicka B; Jadner M; Andersson T; Sederholm C
Br J Cancer; 1997; 76(2):175-9. PubMed ID: 9231916
[TBL] [Abstract][Full Text] [Related]
2. Expression of apoptosis, proliferating cell nuclear antigen, and apoptosis-related antigens (bcl-2, c-myc, Fas, Lewis(y) and p53) in human cholangiocarcinomas and hepatocellular carcinomas.
Terada T; Nakanuma Y
Pathol Int; 1996 Oct; 46(10):764-70. PubMed ID: 8916146
[TBL] [Abstract][Full Text] [Related]
3. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
4. Metallothionein and Fas (CD95) are expressed in squamous cell carcinoma of the tongue.
Sundelin K; Jadner M; Norberg-Spaak L; Davidsson A; Hellquist HB
Eur J Cancer; 1997 Oct; 33(11):1860-4. PubMed ID: 9470847
[TBL] [Abstract][Full Text] [Related]
5. Fas expression is associated with a better prognosis in laryngeal squamous cell carcinoma.
Asensio C; Zapata A; García-Ahijado J; Gil B; Salvadores P; Schneider J
Anticancer Res; 2007; 27(6B):4083-6. PubMed ID: 18225575
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 expression is correlated with low apoptotic index and associated with histopathological grading in esophageal squamous cell carcinomas.
Azmi S; Dinda AK; Chopra P; Chattopadhyay TK; Singh N
Tumour Biol; 2000; 21(1):3-10. PubMed ID: 10601836
[TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of Fas (APO-1/CD95) expression in laryngeal squamous cell carcinoma.
Jäckel MC; Mitteldorf C; Schweyer S; Füzesi L
Head Neck; 2001 Aug; 23(8):646-52. PubMed ID: 11443747
[TBL] [Abstract][Full Text] [Related]
8. Fas antigen expression and its relationship with apoptosis in transplanted kidney.
Kato S; Akasaka Y; Kawamura S
Pathol Int; 1997 Apr; 47(4):230-7. PubMed ID: 9103214
[TBL] [Abstract][Full Text] [Related]
9. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
[TBL] [Abstract][Full Text] [Related]
10. Expression of the apoptosis-mediator Fas is enhanced by dysfunctional mitochondria.
Asoh S; Mori T; Hayashi J; Ohta S
J Biochem; 1996 Sep; 120(3):600-7. PubMed ID: 8902626
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53 protein and the apoptotic regulatory molecules Bcl-2, Bcl-XL, and Bax in locally advanced squamous cell carcinoma of the lung.
Shabnam MS; Srinivasan R; Wali A; Majumdar S; Joshi K; Behera D
Lung Cancer; 2004 Aug; 45(2):181-8. PubMed ID: 15246189
[TBL] [Abstract][Full Text] [Related]
12. Unaltered expression of Fas (CD95/APO-1), caspase-3, Bcl-2 and annexins in brains of fetal Down syndrome: evidence against increased apoptosis.
Engidawork E; Balic N; Juranville JF; Fountoulakis M; Dierssen M; Lubec G
J Neural Transm Suppl; 2001; (61):149-62. PubMed ID: 11771740
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic mechanisms in inflammatory myopathies. Co-expression of Fas and protective Bcl-2 in muscle fibres and inflammatory cells.
Behrens L; Bender A; Johnson MA; Hohlfeld R
Brain; 1997 Jun; 120 ( Pt 6)():929-38. PubMed ID: 9217678
[TBL] [Abstract][Full Text] [Related]
14. Relationship of Fas, FasL, p53 and bcl-2 expression in human non-small cell lung carcinomas.
Li Y; Xu KP; Jiang D; Zhao J; Ge JF; Zheng SY
Int J Clin Exp Pathol; 2015; 8(11):13978-86. PubMed ID: 26823709
[TBL] [Abstract][Full Text] [Related]
15. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions.
Cai W; Devaux B; Schaper W; Schaper J
Atherosclerosis; 1997 Jun; 131(2):177-86. PubMed ID: 9199270
[TBL] [Abstract][Full Text] [Related]
16. Enhanced lymphocyte longevity and absence of proliferation and lymphocyte apoptosis in Quilty effects of human heart allografts.
Dong C; Winters GL; Wilson JE; McManus BM
Am J Pathol; 1997 Jul; 151(1):121-30. PubMed ID: 9212738
[TBL] [Abstract][Full Text] [Related]
17. Protein expression of Fas, Fas ligand, Bcl-2 and TGFbeta2 and correlation with survival in initial and recurrent human gliomas.
Strege RJ; Godt C; Stark AM; Hugo HH; Mehdorn HM
J Neurooncol; 2004; 67(1-2):29-39. PubMed ID: 15072445
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of Bcl-2 protein in early squamous cell carcinoma of the bronchus treated with photodynamic therapy.
Kawaguchi T; Yamamoto S; Naka N; Okishio K; Atagi S; Ogawara M; Hosoe S; Kawahara M; Furuse K
Br J Cancer; 2000 Jan; 82(2):418-23. PubMed ID: 10646898
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis and Fas-ligand expression correlate to the histopathological grade of gastric smooth muscle tumors.
Liu Y; Chen C; Chen C; Hsieh H; Chang C; Shyu J; Yen C; Harn H
J Surg Res; 2001 Feb; 95(2):92-8. PubMed ID: 11162031
[TBL] [Abstract][Full Text] [Related]
20. The implications of proliferation and apoptosis for lung cancer metastasis.
Volm M; Koomagi R
Oncol Rep; 1999; 6(2):373-6. PubMed ID: 10023008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
